Epidemiology and Outcomes Associated with PR Prolongation
Larry R Jackson1, Francis Ugowe2
1Duke University Medical Center, DUMC Box 3860, 2301 Erwin Road, Durham, NC 27710, USA.
Cardiology Clinics
|June 15, 2023
Summary
PR prolongation, a delay in heart
Area of Science:
- Cardiology
- Electrophysiology
- Medical Research
Background:
- PR prolongation signifies delayed electrical conduction within the heart's system.
- Its prevalence increases with age and in patients with heart disease.
- Contemporary research links PR prolongation to adverse cardiac events.
Purpose of the Study:
- To define PR prolongation and its prevalence.
- To highlight contemporary findings on associated risks.
- To emphasize the need for better risk stratification in elderly patients.
Main Methods:
- Literature review of contemporary studies.
- Analysis of prevalence data across age groups.
- Synthesis of research on outcomes associated with PR prolongation.
Main Results:
- PR prolongation affects 1-5% of those under 50, increasing with age.
- Associated risks include atrial arrhythmias, heart failure, and mortality.
- Elderly patients with PR prolongation may face heightened adverse outcomes.
Conclusions:
- PR prolongation is a significant indicator of cardiac electrical conduction delay.
- Increased prevalence and associated risks necessitate further investigation.
- Accurate risk stratification is crucial for managing elderly patients with PR prolongation.
Related Concept Videos
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
221
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
221
01:27Pulmonary Embolism III: Nursing Management
17
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
17
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
15
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
15
01:29Pulmonary Embolism I: Introduction
10
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
10
01:29Venous Thrombosis III: Interprofessional Care
11
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
11
01:23Peripheral Artery Disease V: Postoperative Nursing Management
13
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
13